Adjuvanted trivalent influenza vaccine versus quadrivalent inactivated influenza vaccine in Hutterite Children: A randomized clinical trial-Reference-Cited by-同舟云学术

Adjuvanted trivalent influenza vaccine versus quadrivalent inactivated influenza vaccine in Hutterite Children: A randomized clinical trial

Published:2021-11 Issue:47 Volume:39 Page:6843-6851
ISSN:0264-410X
Container-title:Vaccine
language:en
Short-container-title:Vaccine

Author:

Loeb Mark,Russell Margaret L,Kelly-Stradiotto Caralyn,Fuller Nola,Fonseca Kevin,Earn David J.D.,Chokani Khami^ORCID,Babiuk Lorne,Neupane Binod,Singh Pardeep,Pullenayegum Eleanor^ORCID

Publisher

Elsevier BV

Subject

Infectious Diseases,Public Health, Environmental and Occupational Health,General Veterinary,General Immunology and Microbiology,Molecular Medicine

Reference22 articles.

1. Prevention of influenza in the general population;Langley;CMAJ,2004

2. Influenza-associated hospitalizations in the United States;Thompson;JAMA,2004

3. Age distribution of patients with medically-attended illnesses caused by sequential variants of influenza A/H1N1: comparison to age-specific infection rates, 1978–1989;Glezen;Am J Epidemiol,1991

4. Influenza and the rates of hospitalization for respiratory disease among infants and young children;Izurieta;N Engl J Med,2000

5. Effect of influenza on hospitalizations, outpatient visits, and courses of antibiotics in children;Neuzil;N Engl J Med,2000

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A ferritin nanoparticle vaccine based on the hemagglutinin extracellular domain of swine influenza A (H1N1) virus elicits protective immune responses in mice and pigs;Frontiers in Immunology;2024-05-21

2. Efficacy and safety of pediatric flu vaccination: a systematic review;Revista Española de Quimioterapia;2023-12-05

3. Adjuvant-attenuated symptom severity of influenza infections in vaccinated children;Infectious Medicine;2022-09

4. Immunogenicity and safety of an egg culture-based quadrivalent inactivated non-adjuvanted subunit influenza vaccine in subjects ≥3 years: A randomized, multicenter, double-blind, active-controlled phase III, non-inferiority trial;Vaccine;2022-08